Publications by authors named "Dimpy Rani"

Claim this Profile
C
Contemporary trends on the kinase inhibitors with special reference to quinoxaline derivatives.
Kirti Sharma, Asim Kumar, Srikant Bhagat, Dimpy Rani

Mol Divers· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mirdametinib: FDA approved MEK inhibitor for neurofibromatosis type 1.
Saara, Shweta Kamboj, Dimpy Rani

Cancer Chemother Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancement in chiral heterocycles for the antidiabetic activity.
Tinku Gupta, Dimpy Rani, Lalit Mohan Nainwal, Reena Badhwar

Chirality· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer Potential of Azole Containing Marine Natural Products: Current and Future Perspectives.
Dimpy Rani, Vandana Garg, Rohit Dutt

Anticancer Agents Med Chem· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supramolecular Cocrystals of Gliclazide: Synthesis, Characterization and Evaluation.
Renu Chadha, Dimpy Rani, Parnika Goyal

Pharm Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospection on polymorphism and cocrystallization of anti-retrovirals.
Renu Chadha, Madhu Bala, Dimpy Rani, Poonam Arora

Curr Top Med Chem· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis